Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Helicobacter Infections | 21 | 2013 | 55 | 3.960 |
Why?
|
Stomach Neoplasms | 18 | 2018 | 73 | 3.600 |
Why?
|
Helicobacter felis | 12 | 2013 | 17 | 1.960 |
Why?
|
Bone Marrow Cells | 9 | 2010 | 231 | 1.840 |
Why?
|
Gastric Mucosa | 14 | 2014 | 48 | 1.660 |
Why?
|
Helicobacter pylori | 11 | 2010 | 58 | 1.530 |
Why?
|
Adenocarcinoma | 7 | 2018 | 323 | 1.170 |
Why?
|
fas Receptor | 4 | 2009 | 54 | 1.110 |
Why?
|
Gastritis | 6 | 2014 | 17 | 1.000 |
Why?
|
Cell Transformation, Neoplastic | 8 | 2014 | 192 | 0.930 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2021 | 299 | 0.920 |
Why?
|
Stromal Cells | 4 | 2014 | 65 | 0.910 |
Why?
|
Epithelial Cells | 5 | 2014 | 375 | 0.740 |
Why?
|
Helicobacter | 2 | 2012 | 3 | 0.720 |
Why?
|
Colonic Neoplasms | 2 | 2014 | 213 | 0.680 |
Why?
|
Animals | 39 | 2023 | 19647 | 0.680 |
Why?
|
Cell Proliferation | 8 | 2021 | 945 | 0.650 |
Why?
|
Mice | 27 | 2023 | 10266 | 0.650 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 351 | 0.610 |
Why?
|
Precancerous Conditions | 4 | 2018 | 72 | 0.600 |
Why?
|
Inflammation | 8 | 2023 | 1102 | 0.580 |
Why?
|
Neoplastic Stem Cells | 3 | 2007 | 201 | 0.540 |
Why?
|
Mice, Inbred C57BL | 14 | 2021 | 3194 | 0.530 |
Why?
|
Disease Models, Animal | 8 | 2014 | 2069 | 0.470 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2014 | 76 | 0.450 |
Why?
|
Receptors, CXCR4 | 1 | 2013 | 32 | 0.440 |
Why?
|
Stem Cells | 2 | 2006 | 257 | 0.430 |
Why?
|
Signal Transduction | 10 | 2014 | 2890 | 0.420 |
Why?
|
Apoptosis | 6 | 2009 | 1039 | 0.410 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 254 | 0.410 |
Why?
|
Neoplasms | 3 | 2007 | 1242 | 0.410 |
Why?
|
Colitis | 2 | 2023 | 76 | 0.380 |
Why?
|
Fas Ligand Protein | 2 | 2009 | 39 | 0.370 |
Why?
|
Myofibroblasts | 1 | 2010 | 12 | 0.360 |
Why?
|
Endothelium | 1 | 2010 | 20 | 0.360 |
Why?
|
Barrett Esophagus | 1 | 2010 | 34 | 0.360 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2010 | 30 | 0.350 |
Why?
|
Stem Cell Transplantation | 1 | 2010 | 75 | 0.350 |
Why?
|
Liver Neoplasms | 2 | 2009 | 274 | 0.330 |
Why?
|
Mucins | 3 | 2006 | 23 | 0.330 |
Why?
|
T-Box Domain Proteins | 1 | 2009 | 39 | 0.330 |
Why?
|
Gastrins | 6 | 2014 | 6 | 0.320 |
Why?
|
Cytokines | 6 | 2020 | 906 | 0.320 |
Why?
|
Tea | 1 | 2009 | 26 | 0.320 |
Why?
|
Muscle Proteins | 3 | 2006 | 109 | 0.310 |
Why?
|
Mutation | 2 | 2021 | 2429 | 0.300 |
Why?
|
Anti-Bacterial Agents | 3 | 2009 | 724 | 0.300 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 40 | 0.290 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 44 | 0.290 |
Why?
|
Genes, p53 | 1 | 2007 | 53 | 0.290 |
Why?
|
Hedgehog Proteins | 3 | 2014 | 113 | 0.290 |
Why?
|
Plant Extracts | 1 | 2009 | 161 | 0.290 |
Why?
|
Humans | 29 | 2021 | 59491 | 0.280 |
Why?
|
Point Mutation | 1 | 2007 | 163 | 0.280 |
Why?
|
Gastrointestinal Tract | 1 | 2009 | 171 | 0.280 |
Why?
|
Immunity, Innate | 3 | 2021 | 766 | 0.270 |
Why?
|
Male | 17 | 2021 | 27559 | 0.270 |
Why?
|
Stomach | 4 | 2018 | 84 | 0.270 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2006 | 13 | 0.260 |
Why?
|
Receptor Aggregation | 1 | 2005 | 5 | 0.260 |
Why?
|
Antineoplastic Agents | 2 | 2009 | 645 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2007 | 484 | 0.240 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2005 | 179 | 0.240 |
Why?
|
Toxoplasmosis | 1 | 2004 | 18 | 0.230 |
Why?
|
Toxoplasma | 1 | 2004 | 30 | 0.230 |
Why?
|
Actins | 1 | 2005 | 260 | 0.230 |
Why?
|
Lymphocytes | 2 | 2020 | 194 | 0.220 |
Why?
|
Cells, Cultured | 3 | 2021 | 2104 | 0.210 |
Why?
|
Mice, Knockout | 6 | 2010 | 1989 | 0.210 |
Why?
|
Mice, SCID | 3 | 2014 | 506 | 0.210 |
Why?
|
Cell Differentiation | 4 | 2013 | 1295 | 0.210 |
Why?
|
Mice, Inbred NOD | 3 | 2014 | 515 | 0.200 |
Why?
|
Metaplasia | 3 | 2010 | 18 | 0.200 |
Why?
|
Cell Line, Tumor | 4 | 2011 | 1373 | 0.200 |
Why?
|
Blood Bactericidal Activity | 1 | 2002 | 70 | 0.190 |
Why?
|
Neuropeptides | 1 | 2002 | 82 | 0.190 |
Why?
|
RNA, Long Noncoding | 1 | 2023 | 152 | 0.180 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2002 | 86 | 0.180 |
Why?
|
Ubiquitination | 1 | 2021 | 106 | 0.180 |
Why?
|
Myeloid Cells | 1 | 2021 | 92 | 0.180 |
Why?
|
Dysbiosis | 1 | 2021 | 56 | 0.180 |
Why?
|
Fibroblasts | 2 | 2014 | 370 | 0.180 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2020 | 8 | 0.170 |
Why?
|
Peptides | 4 | 2018 | 549 | 0.170 |
Why?
|
Interferon-gamma | 4 | 2018 | 539 | 0.160 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 2 | 2009 | 9 | 0.160 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 214 | 0.160 |
Why?
|
CTLA-4 Antigen | 1 | 2018 | 66 | 0.150 |
Why?
|
Epithelium | 2 | 2010 | 97 | 0.150 |
Why?
|
Immunohistochemistry | 2 | 2010 | 848 | 0.150 |
Why?
|
Atrophy | 3 | 2006 | 63 | 0.140 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2010 | 581 | 0.140 |
Why?
|
Fluorouracil | 2 | 2014 | 54 | 0.140 |
Why?
|
Carcinogenesis | 1 | 2018 | 116 | 0.140 |
Why?
|
Transfection | 2 | 2009 | 674 | 0.140 |
Why?
|
Disease Progression | 3 | 2007 | 1044 | 0.130 |
Why?
|
Receptors, Histamine H2 | 2 | 2006 | 2 | 0.130 |
Why?
|
Mice, Transgenic | 4 | 2009 | 1221 | 0.130 |
Why?
|
Bone Marrow Transplantation | 2 | 2007 | 133 | 0.130 |
Why?
|
Coculture Techniques | 2 | 2009 | 93 | 0.130 |
Why?
|
Trefoil Factor-2 | 3 | 2006 | 6 | 0.130 |
Why?
|
Female | 7 | 2021 | 30906 | 0.130 |
Why?
|
Membrane Proteins | 1 | 2021 | 842 | 0.130 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2014 | 43 | 0.120 |
Why?
|
HIV-1 | 1 | 2020 | 708 | 0.120 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2014 | 38 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 2 | 2009 | 673 | 0.110 |
Why?
|
Rats | 2 | 2007 | 1912 | 0.100 |
Why?
|
Middle Aged | 5 | 2014 | 16274 | 0.100 |
Why?
|
Neoplasms, Experimental | 1 | 2011 | 74 | 0.090 |
Why?
|
Time Factors | 3 | 2007 | 3579 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2011 | 403 | 0.090 |
Why?
|
Models, Biological | 2 | 2007 | 1142 | 0.090 |
Why?
|
Genes, APC | 1 | 2010 | 9 | 0.090 |
Why?
|
Culture Media, Conditioned | 1 | 2010 | 50 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 183 | 0.090 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 159 | 0.090 |
Why?
|
Transplantation, Homologous | 1 | 2010 | 233 | 0.090 |
Why?
|
Ethanol | 1 | 2013 | 307 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2010 | 45 | 0.090 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 155 | 0.090 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2010 | 37 | 0.090 |
Why?
|
Transplantation, Heterologous | 1 | 2010 | 223 | 0.080 |
Why?
|
Mice, Mutant Strains | 1 | 2010 | 304 | 0.080 |
Why?
|
Mammary Glands, Animal | 1 | 2010 | 79 | 0.080 |
Why?
|
Receptor, Cholecystokinin B | 2 | 2006 | 2 | 0.080 |
Why?
|
In Situ Nick-End Labeling | 1 | 2009 | 43 | 0.080 |
Why?
|
Bone Marrow | 1 | 2010 | 174 | 0.080 |
Why?
|
Mutation, Missense | 1 | 2010 | 179 | 0.080 |
Why?
|
Lymphoproliferative Disorders | 1 | 2009 | 35 | 0.080 |
Why?
|
Homeostasis | 2 | 2023 | 340 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2009 | 59 | 0.080 |
Why?
|
Antigens, CD | 1 | 2010 | 344 | 0.080 |
Why?
|
Aged | 4 | 2014 | 13339 | 0.080 |
Why?
|
Mice, Inbred Strains | 1 | 2009 | 184 | 0.080 |
Why?
|
Hepatitis | 1 | 2009 | 55 | 0.080 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 454 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2010 | 196 | 0.080 |
Why?
|
Cell Movement | 1 | 2010 | 422 | 0.080 |
Why?
|
Gastritis, Atrophic | 2 | 2010 | 3 | 0.080 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 2007 | 4 | 0.070 |
Why?
|
Fibrosarcoma | 1 | 2007 | 13 | 0.070 |
Why?
|
Hepatocytes | 1 | 2009 | 191 | 0.070 |
Why?
|
Cell Line, Transformed | 1 | 2007 | 97 | 0.070 |
Why?
|
Interleukin-1beta | 1 | 2009 | 265 | 0.070 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2007 | 74 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2009 | 105 | 0.070 |
Why?
|
Anticarcinogenic Agents | 1 | 2007 | 77 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2009 | 330 | 0.070 |
Why?
|
Adult | 4 | 2010 | 15782 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2007 | 177 | 0.070 |
Why?
|
Gastrointestinal Diseases | 1 | 2006 | 73 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 1 | 2007 | 502 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2009 | 254 | 0.060 |
Why?
|
Cytochalasin D | 1 | 2005 | 20 | 0.060 |
Why?
|
Drug Design | 1 | 2007 | 143 | 0.060 |
Why?
|
Benzodiazepinones | 1 | 2005 | 2 | 0.060 |
Why?
|
NF-kappa B | 1 | 2007 | 461 | 0.060 |
Why?
|
Histamine H2 Antagonists | 1 | 2005 | 11 | 0.060 |
Why?
|
Tetracycline | 1 | 2005 | 20 | 0.060 |
Why?
|
Intestinal Mucosa | 2 | 2023 | 221 | 0.060 |
Why?
|
Antioxidants | 1 | 2007 | 243 | 0.060 |
Why?
|
Adipocytes | 1 | 2007 | 252 | 0.060 |
Why?
|
Phenylurea Compounds | 1 | 2005 | 29 | 0.060 |
Why?
|
Phosphorylation | 1 | 2007 | 861 | 0.060 |
Why?
|
Triazoles | 1 | 2005 | 53 | 0.060 |
Why?
|
Parietal Cells, Gastric | 1 | 2004 | 1 | 0.060 |
Why?
|
Helicobacter hepaticus | 1 | 2004 | 2 | 0.060 |
Why?
|
Keratins | 1 | 2004 | 31 | 0.060 |
Why?
|
Cell Fusion | 1 | 2004 | 45 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 873 | 0.060 |
Why?
|
Intestines | 2 | 2021 | 157 | 0.060 |
Why?
|
Carcinoma in Situ | 1 | 2004 | 32 | 0.060 |
Why?
|
Virulence | 1 | 2004 | 189 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 1131 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2006 | 258 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2004 | 195 | 0.060 |
Why?
|
Glycine | 1 | 2004 | 45 | 0.060 |
Why?
|
Cadherins | 1 | 2003 | 67 | 0.050 |
Why?
|
Disease Susceptibility | 1 | 2003 | 158 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2010 | 5089 | 0.050 |
Why?
|
Immunoglobulin G | 1 | 2004 | 452 | 0.050 |
Why?
|
Trefoil Factor-3 | 1 | 2002 | 1 | 0.050 |
Why?
|
Gastric Acid | 1 | 2002 | 10 | 0.050 |
Why?
|
Cell Division | 1 | 2004 | 443 | 0.050 |
Why?
|
Growth Substances | 1 | 2002 | 35 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2003 | 150 | 0.050 |
Why?
|
Urease | 1 | 2002 | 9 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2004 | 439 | 0.050 |
Why?
|
Sodium Chloride | 1 | 2002 | 57 | 0.050 |
Why?
|
Diffusion of Innovation | 1 | 2002 | 56 | 0.050 |
Why?
|
Colony Count, Microbial | 1 | 2002 | 57 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2004 | 233 | 0.050 |
Why?
|
Culture Media | 1 | 2002 | 77 | 0.050 |
Why?
|
Breast Neoplasms | 1 | 2010 | 1129 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 669 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2003 | 453 | 0.050 |
Why?
|
Macrophages | 1 | 2006 | 1007 | 0.050 |
Why?
|
Phenotype | 1 | 2004 | 1157 | 0.050 |
Why?
|
Leukocytes, Mononuclear | 1 | 2002 | 238 | 0.050 |
Why?
|
Biopsy | 1 | 2002 | 375 | 0.040 |
Why?
|
Mitochondria | 1 | 2023 | 335 | 0.040 |
Why?
|
Acute Disease | 1 | 2002 | 659 | 0.040 |
Why?
|
Wnt Signaling Pathway | 1 | 2020 | 71 | 0.040 |
Why?
|
Neutrophils | 1 | 2002 | 357 | 0.040 |
Why?
|
Monocytes | 1 | 2021 | 351 | 0.040 |
Why?
|
In Vitro Techniques | 1 | 2020 | 475 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 1095 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2021 | 1063 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2004 | 552 | 0.040 |
Why?
|
Th17 Cells | 1 | 2018 | 54 | 0.040 |
Why?
|
Interleukins | 1 | 2018 | 77 | 0.040 |
Why?
|
Immunologic Memory | 1 | 2020 | 276 | 0.040 |
Why?
|
Diet | 1 | 2002 | 635 | 0.040 |
Why?
|
Antibodies | 1 | 2018 | 177 | 0.040 |
Why?
|
Th1 Cells | 1 | 2018 | 172 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2018 | 158 | 0.030 |
Why?
|
Microbiota | 1 | 2018 | 106 | 0.030 |
Why?
|
Autoimmunity | 1 | 2018 | 224 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 880 | 0.030 |
Why?
|
RNA Interference | 1 | 2018 | 590 | 0.030 |
Why?
|
Chemokine CXCL12 | 1 | 2013 | 15 | 0.030 |
Why?
|
Focal Adhesions | 1 | 2013 | 23 | 0.030 |
Why?
|
Risk Factors | 1 | 2003 | 5015 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 1538 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 193 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 921 | 0.030 |
Why?
|
Succinimides | 1 | 2011 | 17 | 0.020 |
Why?
|
Fluoresceins | 1 | 2011 | 29 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2011 | 18 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2011 | 180 | 0.020 |
Why?
|
Gene Silencing | 1 | 2013 | 377 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 195 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 2010 | 78 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 60 | 0.020 |
Why?
|
Rituximab | 1 | 2009 | 82 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2010 | 169 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2009 | 233 | 0.020 |
Why?
|
Up-Regulation | 1 | 2010 | 364 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2010 | 427 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 355 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2010 | 255 | 0.020 |
Why?
|
Regression Analysis | 1 | 2009 | 484 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 500 | 0.020 |
Why?
|
Survival Rate | 1 | 2009 | 791 | 0.020 |
Why?
|
Receptors, Interleukin-1 | 1 | 2006 | 64 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 98 | 0.020 |
Why?
|
Achlorhydria | 1 | 2005 | 1 | 0.020 |
Why?
|
Receptors, Cholecystokinin | 1 | 2005 | 2 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 455 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 291 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 526 | 0.020 |
Why?
|
Macrophages, Peritoneal | 1 | 2004 | 73 | 0.010 |
Why?
|
Toll-Like Receptor 2 | 1 | 2004 | 220 | 0.010 |
Why?
|
Gene Expression | 1 | 2006 | 810 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2006 | 699 | 0.010 |
Why?
|
Toll-Like Receptor 4 | 1 | 2004 | 348 | 0.010 |
Why?
|
Toll-Like Receptors | 1 | 2004 | 434 | 0.010 |
Why?
|
Survival Analysis | 1 | 2004 | 553 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2004 | 139 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2004 | 645 | 0.010 |
Why?
|
Cell Line | 1 | 2004 | 2015 | 0.010 |
Why?
|
Young Adult | 1 | 2009 | 4329 | 0.010 |
Why?
|
Prognosis | 1 | 2004 | 1572 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2009 | 5183 | 0.010 |
Why?
|